Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Therapeutic Drug Carrier Systems
Импакт фактор: 2.9 5-летний Импакт фактор: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN Печать: 0743-4863
ISSN Онлайн: 2162-660X

Выпуски:
Том 38, 2021 Том 37, 2020 Том 36, 2019 Том 35, 2018 Том 34, 2017 Том 33, 2016 Том 32, 2015 Том 31, 2014 Том 30, 2013 Том 29, 2012 Том 28, 2011 Том 27, 2010 Том 26, 2009 Том 25, 2008 Том 24, 2007 Том 23, 2006 Том 22, 2005 Том 21, 2004 Том 20, 2003 Том 19, 2002 Том 18, 2001 Том 17, 2000 Том 16, 1999 Том 15, 1998 Том 14, 1997 Том 13, 1996 Том 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v25.i3.10
pages 207-258

Mucoadhesion and the Gastrointestinal Tract

Felipe J. O. Varum
Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra 3000-295, Portugal; and Department of Pharmaceutics, The School of Pharmacy, University of London, London WC1N 1 AX, UK
Emma L. McConnell
Department of Pharmaceutics, The School of Pharmacy, University of London, London WC1N 1 AX, UK
Joao J. S. Sousa
Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra 3000-295, Portugal
Francisco Veiga
Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra 3000-295, Portugal
Abdul W. Basit
Department of Pharmaceutics, The School of Pharmacy, University of London, London WC1N 1 AX, UK

Краткое описание

The concept of mucoadhesion is one that has the potential to improve the highly variable residence times experienced by drugs and dosage forms at various sites in the gastrointestinal tract, and consequently, to reduce variability and improve efficacy. Intimate contact with the mucosa should enhance absorption or improve topical therapy. A variety of approaches have been investigated for mucoadhesion in the gastrointestinal tract, particularly for the stomach and small intestine. Despite interesting results in these sites, mucoadhesive approaches have not yet shown success in humans. The potential of the lower gut for these applications has been largely neglected, although the large intestine in particular may benefit, and the colon has several factors that suggest mucoadhesion could be successful there, including lower motility and the possibility of a lower mucus turnover and thicker mucus layer. In vitro studies on colonic mucoadhesion show promise, and rectal administration has shown some positive results in vivo. This review considers the background to mucoadhesion with respect to the physiological conditions of the gastrointestinal tract as well as the principles that underlie this concept. Mucoadhesive approaches to gastrointestinal drug delivery will be examined, with particular attention given to the lower gut.


Articles with similar content:

Role of Block Copolymer Nanoconstructs in Cancer Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 2
H. G. Agrawal, K. K. Upadhyay, C. Schatz, Sebastian Lecommandoux, J. F. Le Meins, Ambikanandan Misra, C. Upadhyay
Pulmonary Drug Delivery: Physiologic and Mechanistic Aspects
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.14, 1997, issue 4
Jianwei Yu, Yie W. Chien
Nanocurcumin: A Promising Therapeutic Advancement over Native Curcumin
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 4
Deepesh Gupta, Archana Tiwari, Gagan Flora
Electroporation Therapy of Solid Tumors
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.16, 1999, issue 6
S. B. Dev, G. S. Nanda, D. Rabussay, G. A. Hofmann
Approaches and Opportunities in Colon-Specific Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.12, 1995, issue 2-3
Abraham Rubinstein